We curated gene sets associated with resistance to Bevacizumab (an anti-VEGF antibody) in breast cancer patients34 or in a glioblastoma (GBM) xenograft (GSE37956)35 (Table S1). This evidence concerns the gene VEGFA and glioblastoma.